MR. TODD A. GOODGLICK, MD

CHEVY CHASE, MD

Research Active
Ophthalmology - Ophthalmic Plastic and Reconstructive Surgery NPI registered 21+ years 6 publications 1996 – 2018 NPI: 1053315036
Tomography, X-Ray ComputedAntineoplastic AgentsDiagnosis, DifferentialRituximabFluorescein AngiographyFundus OculiTomography, Optical CoherenceAntibodies, Antineutrophil CytoplasmicRadiotherapy, AdjuvantAntibodies, Monoclonal, Murine-DerivedLymphoma, B-Cell, Marginal ZoneOrbital NeoplasmsPanuveitisBlindnessChoroid Diseases

Practice Location

5530 WISCONSIN AVE STE 1209
CHEVY CHASE, MD 20815-4301

Phone: (301) 841-6595

What does TODD GOODGLICK research?

Mr. Goodglick studies a range of medical conditions related to the eyes and serious systemic diseases. He works on developing guidelines for better care of conditions like myotonic dystrophy, which affects muscle function and can have complicated health implications. His research also investigates how tumors and inflammation in the eye can mimic one another, assisting doctors in distinguishing between benign and serious health issues. By uncovering potential microbial links to conditions like giant cell arteritis, he aims to improve understanding and treatment options for patients suffering from these complex diseases.

Key findings

  • Created care guidelines for myotonic dystrophy based on input from 66 international experts, resulting in a 4-page Quick Reference Guide and a detailed document covering 19 health areas.
  • In a case study on orbital lymphoma, treatment led to significant improvement in a patient with prior misdiagnosed eye inflammation, showcasing the importance of accurate diagnosis.
  • Found no infections in a patient with an orbital 'pseudo-abscess,' highlighting the need for careful diagnostic procedures to avoid unnecessary surgeries.
  • Identified 10 microbial gene fragments associated with giant cell arteritis, indicating that microbes may play a role in the disease.
  • Demonstrated that postoperative radiation therapy prevented recurrence of sphenoid wing meningiomas in 42 out of 42 patients, compared to a 89% recurrence rate in patients who did not receive radiation.

Frequently asked questions

Does Dr. Goodglick study myotonic dystrophy?
Yes, he has developed care guidelines to improve treatment for adults with myotonic dystrophy type 1.
What eye conditions has Dr. Goodglick researched?
He has researched conditions such as orbital lymphoma, eye inflammation, and complications from granulomatous sclerouveitis.
Is Dr. Goodglick's work relevant to patients with giant cell arteritis?
Yes, his research has identified potential microbial links to giant cell arteritis, offering insights for better diagnosis and treatment.
What treatments has Dr. Goodglick investigated for brain tumors?
He studied the effects of postoperative radiation therapy in preventing the recurrence of sphenoid wing meningiomas.
How can Dr. Goodglick's research help doctors?
His findings provide critical insights that enhance diagnostic accuracy and treatment strategies for various serious medical conditions.

Publications in plain English

Consensus-based care recommendations for adults with myotonic dystrophy type 1.

2018

Neurology. Clinical practice

Ashizawa T, Gagnon C, Groh WJ, Gutmann L, Johnson NE +61 more

Plain English
Researchers studied how to improve care for adults with myotonic dystrophy type 1 (DM1), a serious genetic condition that affects between 1 in 3,000 and 8,000 people worldwide. They gathered input from 66 international experts to create clear care guidelines, resulting in a brief 4-page Quick Reference Guide and a detailed 55-page document covering 19 different health areas. These recommendations aim to improve the quality of care and ensure that patients receive consistent treatment across different medical settings. Who this helps: This benefits patients with myotonic dystrophy and their healthcare providers.

PubMed

Orbital 'pseudo-abscess' in a patient with spontaneous subluxation of globe: A case report.

2017

American journal of ophthalmology case reports

Mylvaganam H, Goodglick T

Plain English
This paper discusses a case of a 58-year-old woman who was thought to have an infection in her eye due to a buildup of fluid behind the eyeball. After surgery, doctors found no infection, just clear fluid caused by pressure differences in blood flow around the eye. This matters because it highlights the need for careful interpretation of similar cases, as not all fluid collections behind the eye are infections, which can prevent unnecessary surgery. Who this helps: This helps doctors better diagnose eye conditions, particularly in patients with similar issues.

PubMed

Orbital lymphoma masquerading as panuveitis.

2010

Ocular immunology and inflammation

Panda P, Forooghian F, Goodglick T, Chan CC, Nussenblatt R +1 more

Plain English
This study looked at a 53-year-old woman who had serious eye problems that seemed to be caused by inflammation, but it turned out she had a type of cancer called orbital MALT lymphoma. After treating her with radiation and a special medication, her eye issues improved significantly. This matters because it shows that what appears to be a common eye inflammation could actually be a serious condition that needs different treatment. Who this helps: Patients with eye inflammation who might actually have lymphoma.

PubMed

Recalcitrant granulomatous sclerouveitis in a patient with granulomatous ANCA-associated vasculitis.

2009

Ocular immunology and inflammation

Levy-Clarke G, Ding X, Gangaputra S, Yeh S, Goodglick T +3 more

Plain English
This study looks at a patient with a rare eye condition caused by a type of vasculitis, which is an inflammation of the blood vessels. The patient suffered severe eye damage despite trying several treatments, eventually losing the eye. Findings showed a strong immune response affecting the eye tissue, which is important because it highlights a serious complication that can arise from this type of vasculitis, potentially leading to blindness. Who this helps: This helps patients with ANCA-associated vasculitis and their doctors by providing insight into possible severe eye complications.

PubMed

Identification of candidate microbial sequences from inflammatory lesion of giant cell arteritis.

2004

Clinical immunology (Orlando, Fla.)

Gordon LK, Goldman M, Sandusky H, Ziv N, Hoffman GS +2 more

Plain English
The study looked into whether microbes might be involved in causing giant cell arteritis (GCA), a condition that leads to inflammation in the arteries, especially in older adults. Researchers found 10 gene fragments from bacteria in tissue samples of people with GCA, and they identified three strong candidates that could be linked to the disease. The presence of specific antibodies in the blood of patients with GCA further supports the idea that these microbes may play a role in the illness. Who this helps: This research benefits patients with giant cell arteritis and doctors treating them.

PubMed

The role of postoperative irradiation in the management of sphenoid wing meningiomas. A preliminary report.

1996

Ophthalmology

Peele KA, Kennerdell JS, Maroon JC, Kalnicki S, Kazim M +4 more

Plain English
This study looked at how well radiation therapy after surgery helps prevent the return of sphenoid wing meningiomas, which are a type of brain tumor. Researchers followed 86 patients and found that none of the 42 who received radiation experienced a tumor return over an average of about 4 years. In comparison, 16 out of 18 patients without radiation had a recurrence within roughly 4 years. This is important because it shows that radiation therapy can significantly reduce the chances of these tumors coming back after incomplete surgery. Who this helps: This benefits patients with sphenoid wing meningiomas who have had incomplete surgical removal of their tumors.

PubMed

Frequent Co-Authors

Chi-Chao Chan Robert Nussenblatt Tetsuo Ashizawa Cynthia Gagnon William J Groh Laurie Gutmann Nicholas E Johnson Giovanni Meola Richard Moxley Shree Pandya

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.